Advanced

Pharmaceuticals in the aquatic environment - The role of decentralised wastewater treatment in Risk management

Yliruusi, Hannamaria LU (2008) IMEN41 20081
The International Institute for Industrial Environmental Economics
Abstract
There are more than 80 pharmaceuticals and pharmaceutical metabolites detected in the aquatic environment. Regarding negative impacts of these compounds, the main concern lays in sensitive aquatic environment and long-term effects regarding human health and the environment. Although we have procedures to assess the risk that pharmaceutical residues represent to the environment, these procedures include various assumptions and data gaps. Therefore current knowledge is not enough to say how serious the threat is that we are dealing with.
Many concerned governments and organisations apply the precautionary principle (PP) regarding the potential risks that pharmaceuticals in the aquatic environment present. This means that while there is no... (More)
There are more than 80 pharmaceuticals and pharmaceutical metabolites detected in the aquatic environment. Regarding negative impacts of these compounds, the main concern lays in sensitive aquatic environment and long-term effects regarding human health and the environment. Although we have procedures to assess the risk that pharmaceutical residues represent to the environment, these procedures include various assumptions and data gaps. Therefore current knowledge is not enough to say how serious the threat is that we are dealing with.
Many concerned governments and organisations apply the precautionary principle (PP) regarding the potential risks that pharmaceuticals in the aquatic environment present. This means that while there is no full proof about such risks, risk management alternatives are nevertheless developed and assessed. In this thesis preventative alternatives and treatment alternatives of risk management are discussed. Preventative alternatives include source control and source separation as well as increasing awareness. Treatment alternatives include wastewater treatment both in centralised systems and decentralised systems.
Current knowledge about how effective decentralised systems are in removing pharmaceuticals is not sufficient. To be able to assess the role that decentralised wastewater systems can have in risk management, pharmaceutical removal effectiveness of a bench scale recirculating biofilter (RBF) was observed in laboratory experiments. The objective was to test if a nitrifying biofilter was able to remove four selected pharmaceuticals (ibuprofen, gemfibrozil, naproxen and diclofenac) from pre-treated wastewater. According to the laboratory results, ibuprofen, gemfibrozil and naproxen were removed more than 90 percent and diclofenac was removed with approximately 70 percent efficiency. These results show that there is potential in decentralised systems regarding pharmaceutical removal. However more research is needed.
Local conditions regarding pharmaceutical use patterns, water consumption, and treatment technology have an effect on determining the most efficient way to manage this environmental risk. Therefore efficient risk management includes both preventative and treatment approaches. (Less)
Please use this url to cite or link to this publication:
author
Yliruusi, Hannamaria LU
supervisor
organization
course
IMEN41 20081
year
type
H2 - Master's Degree (Two Years)
subject
keywords
Aquatic environment, risk management
language
English
id
1480552
date added to LUP
2009-09-29 13:00:44
date last changed
2009-09-29 13:00:44
@misc{1480552,
  abstract     = {There are more than 80 pharmaceuticals and pharmaceutical metabolites detected in the aquatic environment. Regarding negative impacts of these compounds, the main concern lays in sensitive aquatic environment and long-term effects regarding human health and the environment. Although we have procedures to assess the risk that pharmaceutical residues represent to the environment, these procedures include various assumptions and data gaps. Therefore current knowledge is not enough to say how serious the threat is that we are dealing with.
Many concerned governments and organisations apply the precautionary principle (PP) regarding the potential risks that pharmaceuticals in the aquatic environment present. This means that while there is no full proof about such risks, risk management alternatives are nevertheless developed and assessed. In this thesis preventative alternatives and treatment alternatives of risk management are discussed. Preventative alternatives include source control and source separation as well as increasing awareness. Treatment alternatives include wastewater treatment both in centralised systems and decentralised systems.
Current knowledge about how effective decentralised systems are in removing pharmaceuticals is not sufficient. To be able to assess the role that decentralised wastewater systems can have in risk management, pharmaceutical removal effectiveness of a bench scale recirculating biofilter (RBF) was observed in laboratory experiments. The objective was to test if a nitrifying biofilter was able to remove four selected pharmaceuticals (ibuprofen, gemfibrozil, naproxen and diclofenac) from pre-treated wastewater. According to the laboratory results, ibuprofen, gemfibrozil and naproxen were removed more than 90 percent and diclofenac was removed with approximately 70 percent efficiency. These results show that there is potential in decentralised systems regarding pharmaceutical removal. However more research is needed.
Local conditions regarding pharmaceutical use patterns, water consumption, and treatment technology have an effect on determining the most efficient way to manage this environmental risk. Therefore efficient risk management includes both preventative and treatment approaches.},
  author       = {Yliruusi, Hannamaria},
  keyword      = {Aquatic environment,risk management},
  language     = {eng},
  note         = {Student Paper},
  title        = {Pharmaceuticals in the aquatic environment - The role of decentralised wastewater treatment in Risk management},
  year         = {2008},
}